Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Proceedings (Baylor University. Medical Center)|July 2, 2013
Eosinophilic small bowel enteritis in response to folinic acid, fluorouracil, and oxaliplatin chemotherapyEdward J Pearson, Robert MennelProceedings (Baylor University. Medical Center)|November 3, 2011
Primary cutaneous large B-cell lymphoma, leg typeVibha Thomas, Robin Dobson, Robert MennelProceedings (Baylor University. Medical Center)|January 26, 2012
Primary cutaneous angiosarcoma of the breast after breast traumaYing Cao, Laura Panos, Robbie L Graham, et al.Cancer Investigation|December 27, 2005
Phase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumorsJohn Nemunaitis, Casey Cunningham, Neil Senzer, et al.Cancer Journal (Sudbury, Mass.)|February 27, 2003
Phase I study of oral CI-994 in combination with gemcitabine in treatment of patients with advanced cancerJohn J Nemunaitis, Douglas Orr, Rob Eager, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancerLyndsay Harris, Herbert Fritsche, Robert Mennel, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2016
Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's SarcomaMaurizio Ghisoli, Minal Barve, Robert Mennel, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 29, 2015
Pilot Trial of FANG Immunotherapy in Ewing's SarcomaMaurizio Ghisoli, Minal Barve, Reva Schneider, et al.Journal of Pediatric Hematology/Oncology|March 25, 2017
Case Report: Immune-mediated Complete Response in a Patient With Recurrent Advanced Ewing Sarcoma (EWS) After Vigil ImmunotherapyMaurizio Ghisoli, McCarley Rutledge, Philip J Stephens, et al.Clinical Breast Cancer|July 19, 2002
Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node-negative breast cancerStephen E Jones, Gary Clark, Sherry Koleszar, et al.Pageof 1